- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 191.64M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 195M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 201M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 207M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 213M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $958M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $316M |
| Capex | Q3 2025 · Sep 30, 2025 | $849M |
| Capex | Q3 2025 · Sep 30, 2024 | $286M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $1.79B |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $1.35B |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $11.16B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $9.81B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $777M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $996M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $732M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $966M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.97B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $2.29B |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $2.78B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $2.48B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $2.52B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $3.62B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $3.3B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $2.91B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $7.71B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $8.81B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $22B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $21.54B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $8.12B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $8.96B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $23.97B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $24.02B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.69 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $3.72 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$3.79 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $2.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.70 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $3.81 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$3.79 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $2.08 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $612M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.89B |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $645M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $1.74B |
| Net Income | Q3 2025 · Sep 30, 2025 | $152M |
| Net Income | Q3 2025 · Sep 30, 2025 | $798M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$767M |
| Net Income | Q3 2025 · Sep 30, 2024 | $482M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $414M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $1.55B |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$812M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $1.47B |
| Revenue | Q3 2025 · Sep 30, 2025 | $7.5B |
| Revenue | Q3 2025 · Sep 30, 2025 | $22.67B |
| Revenue | Q3 2025 · Sep 30, 2024 | $7.13B |
| Revenue | Q3 2025 · Sep 30, 2024 | $20.99B |